Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
about
Defining Low Disease Activity in Systemic Lupus Erythematosus.Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort.Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study.Decreased ex vivo production of interferon-gamma is associated with severity and poor prognosis in patients with lupus.Lupus in the far east: a modern epidemic.Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art.Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.Treat to target in systemic lupus erythematosus: a commentary.Systemic lupus erythematosus diagnosis and management.It hasn't gone away: the problem of glucocorticoid use in lupus remains.The ratio of circulating follicular T helper cell to follicular T regulatory cell is correlated with disease activity in systemic lupus erythematosus.Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus.Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein can reflect systemic lupus erythematosus activity.Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab.Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohort.Kynurenine pathway is altered in patients with SLE and associated with severe fatigue.TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.
P2860
Q33435736-F2339042-285E-4A3B-816F-50E6D86D4F84Q36188027-0D3F355F-046E-4B43-832E-1824A9A3DC32Q36315477-86FE2142-126F-4F62-96E4-C711076537DEQ38607989-D95562B2-A935-4EAA-AAE1-ADE780928601Q38672989-6D63E604-34C1-4A8C-AAF1-A5176E015C52Q38690844-56F0A5C7-6027-47BE-95A5-37252F3C6461Q38800659-C4BF6F92-BFEA-482E-A144-C6967C8E6A31Q38894396-D8D5E9EF-B167-4331-AAE0-D982163E159AQ39053129-A4C9CCC1-C8BD-4266-965B-5EC7F441E80BQ39053147-DB51A07B-7E1D-42EC-A87B-E2178D5118E7Q43986231-AEB820A3-951C-4543-8501-94576B5905B8Q44750823-0D20FB7D-644B-415A-B36E-0F04BF500690Q47302001-5B583018-BFF5-4FCE-967A-C6FF399A82A8Q50053733-373281D1-2083-4B1C-81E0-437D4F306545Q54958462-8630DEC5-6DC1-4F19-B4D9-D0956A8569B6Q55035261-BB82D65C-BBDD-488E-834D-799F6A73CFD2Q55379196-4183D821-F206-4E8A-8E09-EC1C1E00B246Q55401570-6123F488-9CDA-47FA-B0B8-7216F87F0E94
P2860
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
@ast
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
@en
type
label
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
@ast
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
@en
prefLabel
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
@ast
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
@en
P2093
P2860
P50
P1476
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
@en
P2093
Aisha Lateef
Alberta Hoi
Asia-Pacific Lupus Collaboration
C Singgih Wahono
Kate Franklyn
Mandana Nikpour
Sandra V Navarra
Shun Le Chen
P2860
P304
P356
10.1136/ANNRHEUMDIS-2015-207726
P407
P577
2015-10-12T00:00:00Z